Drugs / ZT 1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00423228 | Feb 2007 → Apr 2009 | Alzheimer disease | Debiopharm International SA | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZT 1 | “This is a multicenter, randomised, double-blind, double-dummy, oral donepezil controlled study on the safety and efficacy of repeated monthly s.c. injections of a...” NCT00423228 ↗ |
| Action | Inhibit | “ZT-1 is a new drug derived from a plant extract already used in China for memory disorders, which blocks the action of the enzyme and restores adequate levels of acetylcholine.” NCT00423228 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “ZT-1 is a new drug derived from a plant extract already used in China for memory disorders” NCT00423228 ↗ |
| Route | Oral | “ZT 1-1 mg capsules administered p.o. daily during the first month of treatment” NCT00423228 ↗ |
| Route | Subcutaneous | “ZT 1-1 mg capsules administered p.o. daily during the first month of treatment” NCT00423228 ↗ |